![logo](/logos/PA8.DE.webp)
Paion AG
FSX:PA8.DE
0.36 (EUR) • At close November 1, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Paion AG |
Symbool | PA8.DE |
Munteenheid | EUR |
Prijs | 0.36 |
Beurswaarde | 2,709,497 |
Dividendpercentage | 0% |
52-weken bereik | 0.224 - 9.8 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Tilmann Bur |
Website | https://www.paion.com |
An error occurred while fetching data.
Over Paion AG
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)